CAVINTON

This brand name is authorized in Ecuador, Estonia, Lithuania, Poland, Romania, Singapore.

Active ingredients

The drug CAVINTON contains one active pharmaceutical ingredient (API):

1
UNII 543512OBTC - VINPOCETINE
 
Read more about Vinpocetine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N06BX18 Vinpocetine N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BX Other psychostimulants and nootropics
Discover more medicines within N06BX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 367520813
EE Ravimiamet 1088052
LT Valstybinė vaistų kontrolės tarnyba 1002956, 1003646, 1004547, 1005104, 1005105, 1015313, 1058185, 1058186, 1058187, 1066905, 1067515, 1073942, 1078644, 1078645, 1079685, 1080183, 1081429, 1082391, 1087829, 1087830, 1087831, 1088488
PL Rejestru Produktów Leczniczych 100013169, 100013175, 100120095, 100260212, 100263239, 100265706, 100265965, 100269503, 100292413, 100292650, 100294949, 100324290, 100349716, 100351676, 100393083, 100396740, 100398123, 100418794, 100424091, 100425417, 100426256, 100435901, 100437001
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W54827001, W54827002, W54828001
SG Health Sciences Authority 00396P

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈